Michelle Farnan Discusses the Impact of Using a Palliative Care Screening Tool

Video
Conferences|Palliative Care In Oncology Symposium

Michelle Farnan, RN, MSN, OCN, palliative care nurse coordinator, Penn State Hershey Medical Center, discusses the impact of a palliative care screening tool for inpatient oncology patients.

Michelle Farnan, RN, MSN, OCN, palliative care nurse coordinator, Penn State Hershey Medical Center, discusses the impact of a palliative care screening tool for inpatient oncology patients.

Farnan says the tool, which is currently used at her institution, looks at the patient’s diagnosis, comorbid conditions, functional status and additional symptoms related to what the patient is experiencing.

The study validated that with oncology patients, the level of distress is high and that nurses need to find a time prior to an oncology patient’s first hospital visit to begin the discussion on palliative care, Farnan says.

<<<

View more from the Palliative Care in Oncology Symposium

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
Photo of a man wearing a suit with a blue tie in front of a dark blue background
Photo of a man wearing glasses and a suit in front of a blue background
Photo of a man wearing a suit with a blue tie in front of a dark blue background
Photo of Hope Rugo, MD
Image of a woman with blond hair in front of a dark blue background
Image of a man in a suit smiling in front of an Oncology Nursing News background
Photo of a woman wearing a blazer in front of an Oncology Nursing News backdrop
Photo of a white man with curly hair and in front of a blue Oncology Nursing News backdrop
Image of a woman with gray hair and glasses in front of a blue Oncology Nursing News background
Photo of a woman with blond wavy hair wearing a blazer in front of a blue Oncology Nursing News background
Related Content
Line illustration of a pair of kidneys with a tumor on the left kidney

Belzutifan May Lengthen Quality-Adjusted Survival in Advanced RCC

Russ Conroy
July 21st 2025
Article

A quality-adjusted time without symptoms or toxicity analysis identified better outcomes for patients with RCC treated with belzutifan vs everolimus.

The Vitals

Nicole Gay Shares How She Counsels Patients on Lung Cancer Screenings

Lindsay Fischer
November 15th 2023
Podcast

Nicole Gay, APRN-C, shares how nurse navigators can talk to their patients about lung cancer screening.

Graphic of a kidney

Neoantigen Vaccine Shows Promise in Mutated Renal Cell Carcinoma

Ashling Wahner
July 18th 2025
Article

A personalized neoantigen vaccine may be effective in patients with clear cell renal cell carcinoma, shared David A. Braun, MD, PhD.

Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

Lindsay Fischer
October 2nd 2023
Podcast

Ryan Tamargo, NP, AONCP, discusses the launch of an online inflammatory breast cancer scoring system tool.

Graphic of kidneys

Allogenic CAR T-Cell Agent Safe, Active in Heavily Pretreated RCC

Kyle Doherty
July 1st 2025
Article

ALLO-316 showed significant activity and safety in patients with metastatic CD70-positive clear cell renal cell carcinoma.

Illustration of a diagram of the colon surrounded by medical charts and equipment

No Survival, Recurrence Benefit With Aspirin in CRC Liver Metastases

Tim Cortese
June 25th 2025
Article

Adjuvant aspirin did not reduce recurrence or improve survival in patients with CRC liver metastases, phase 3 data showed at the 2025 ASCO Meeting.